Paolo Farneti/LinkedIn
Aug 11, 2025, 01:43
Delphi Consensus: A Safe Guide to Use of Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-related Epistaxis
JAMA Otolaryngology – Head & Neck Surgery shared an insightful post on X:
”A Delphi consensus among six international experts established 30 statements to guide the safe and effective use of sclerotherapy for hereditary hemorrhagic telangiectasia (HHT)-related epistaxis.”
Read the full article here.
Article: Consensus on Sclerotherapy for Patients With Hereditary Hemorrhagic Telangiectasia–Related Epistaxis
Authors: Paolo Farneti, Sol Marcos-Salazar, Claudia Crocione,Holly Boyer, Roberto Puxeddu, Alan B. Whitehouse, Jay F. Piccirillo
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood
-
Feb 16, 2026, 14:44Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES